These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3424417

  • 1. Comparison of digoxin-like immunoreactive substance cross-reactivity with two digoxin immunoassays in normotensive third trimester pregnancy.
    Phelps S, Hammond K, Bottorff M, Sibai B.
    Ther Drug Monit; 1987 Dec; 9(4):489. PubMed ID: 3424417
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Digoxin-like immunoreactive substance in pregnancy.
    González AR, Phelps SJ, Cochran EB, Sibai BM.
    Am J Obstet Gynecol; 1987 Sep; 157(3):660-4. PubMed ID: 2820228
    [Abstract] [Full Text] [Related]

  • 4. The influence of gestational age and preeclampsia on the presence and magnitude of serum endogenous digoxin-like immunoreactive substance(s).
    Phelps SJ, Cochran EB, Gonzalez-Ruiz A, Tolley EA, Hammond KD, Sibai BM.
    Am J Obstet Gynecol; 1988 Jan; 158(1):34-9. PubMed ID: 3337179
    [Abstract] [Full Text] [Related]

  • 5. Digoxin-like immunoreactive substance: monoclonal and polyclonal RIA and FPIA compared.
    Mojaverian P, Green PJ, Jhangiania RK, Chase GD.
    J Pharm Biomed Anal; 1989 Jan; 7(5):585-92. PubMed ID: 2490762
    [Abstract] [Full Text] [Related]

  • 6. Endogenous digoxin-immunoactive factor in human subjects.
    Valdes R.
    Fed Proc; 1985 Sep; 44(12):2800-5. PubMed ID: 3839758
    [Abstract] [Full Text] [Related]

  • 7. Identification of progesterone and cortisol as immunoreactive plasma digitalis like factors in pregnancy.
    Longerich L, Brent DA, Johnson RL, Vasdev S, Gault MH.
    Res Commun Chem Pathol Pharmacol; 1988 Mar; 59(3):383-93. PubMed ID: 2834807
    [Abstract] [Full Text] [Related]

  • 8. Endogenous digoxin-immunoreactive substance in normal and preeclamptic pregnancies.
    Loğoğlu G, Erdoğan S, Ozgünen FT, Doğan A, Ozgünen T, Kadayifçi O.
    Int J Gynaecol Obstet; 1993 Nov; 43(2):137-43. PubMed ID: 7905428
    [Abstract] [Full Text] [Related]

  • 9. Methods for eliminating interferences in digoxin immunoassays caused by digoxin-like factors.
    Graves SW, Sharma K, Chandler AB.
    Clin Chem; 1986 Aug; 32(8):1506-9. PubMed ID: 3755385
    [Abstract] [Full Text] [Related]

  • 10. Comparison of digoxin-like immunoreactive substance cross-reactivity with two digoxin automated immunoassay.
    Lacarelle B, Durand A, Labadie N, Cano JP.
    Ther Drug Monit; 1989 Nov; 11(6):725-7. PubMed ID: 2595757
    [No Abstract] [Full Text] [Related]

  • 11. Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods.
    Morris RG, Frewin DB, Saccoia NC, Goldsworthy WL, Jeffries WS, McPhee AJ.
    Eur J Clin Pharmacol; 1990 Nov; 39(4):359-63. PubMed ID: 2076718
    [Abstract] [Full Text] [Related]

  • 12. Digoxin-like immunoreactive factor in twin and pregnancy-associated hypertensive pregnancies.
    Jakobi P, Krivoy N, Weissman A, Paldi E.
    Obstet Gynecol; 1989 Jul; 74(1):29-33. PubMed ID: 2733937
    [Abstract] [Full Text] [Related]

  • 13. A longitudinal study of maternal digoxin-like immunoreactive substances in normotensive pregnancy and pregnancy-induced hypertension.
    Kerkez SA, Poston L, Wolfe CD, Quartero HW, Carabelli P, Petruckevitch A, Hilton PJ.
    Am J Obstet Gynecol; 1990 Mar; 162(3):783-7. PubMed ID: 2316589
    [Abstract] [Full Text] [Related]

  • 14. Radioimmunoassay of digoxin in serum using monoclonal antibodies and assessment of interference by digoxin-like immunoreactive substances.
    Loucari-Yiannakou E, Yiannakou L, Souvatzoglou A, Diamandis EP.
    Ther Drug Monit; 1990 Mar; 12(2):195-200. PubMed ID: 2315977
    [Abstract] [Full Text] [Related]

  • 15. Effect of digoxin-like immunoreactive substances on the "Dac-Cel" digoxin assay.
    Smith RL.
    Clin Chem; 1987 Sep; 33(9):1697. PubMed ID: 3621591
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Assessment of the immunoreactivity of digoxin metabolites and the cross-reactivity with digoxin-like immunoreactive factors in the Roche-TDM ONLINE digoxin assay.
    Bonagura E, Law T, Rifai N.
    Ther Drug Monit; 1995 Oct; 17(5):532-7. PubMed ID: 8585119
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Digoxin-like immunoreactive substances in the perinatal period.
    Seccombe DW, Pudek MR.
    Lancet; 1987 Apr 25; 1(8539):983. PubMed ID: 2882377
    [No Abstract] [Full Text] [Related]

  • 20. Tentative identification of a digoxin-like immunoreactive substance.
    Toseland PA, Oldfield PR, Murphy GM, Lawson AM.
    Ther Drug Monit; 1988 Apr 25; 10(2):168-71. PubMed ID: 3381233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.